Which pharmaceutical advertising innovation first allowed direct-to-consumer (DTC) prescription drug TV ads to omit the full list of side effects, revolutionizing pharmaceutical marketing in 1997?

The pharmaceutical industry spends billions on advertising and marketing campaigns each year. While medical products must adhere to strict regulatory guidelines for promotion, some campaigns have revolutionized how medications are marketed to both healthcare professionals and consumers. This trivia tests your knowledge of a groundbreaking pharmaceutical advertising approach that changed the industry landscape.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

The 'Major Statement' rule, requiring only major risks be disclosed verbally with full information available elsewhere
The 'Physician-Only' provision, allowing simplified ads if they directed consumers to consult doctors for full information
The 'Digital Disclosure' amendment, permitting reduced TV disclosures if comprehensive information was available online
The 'Comparative Benefit' exception, allowing simplified risk statements when balanced with equal time for benefit explanation